Tag: la jolla

September 27, 2016

New Study Opens Window for OncBioMune Cancer Vaccine in Early and Advanced Prostate Cancer Patients

BATON ROUGE, LA, Sept. 27, 2016 /PRNewswire/ - Treatment for newly diagnosed prostate cancer remains controversial, largely due to the...
September 15, 2016

Celyad CEO to present at the 2016 Cell & Gene Meeting

Celyad, a leader in the discovery and development of engineered cell therapies, today announced that Dr. Christian Homsy, Chief Executive...
September 1, 2016

MDA Awards $6.7 Million in New Research Grants

CHICAGO, Sept. 1, 2016 /PRNewswire-USNewswire/ — The Muscular Dystrophy Association today announced the award of 25 new research, development and research...
August 8, 2016

OncBioMune Announce Latest Data From Phase 1 Trial of ProscaVax for Prostate Cancer

OncBioMune Pharmaceuticals (OTCMKTS:OBMP), a clinical stage biopharmaceutical company engaged in the development of novel cancer products and a proprietary vaccine...
June 7, 2016

MyDx Provides Positive Mid-Year Update as Part of Special Letter to Shareholders

Highlights: MyDx experiencing double-digit quarterly revenue growth following commercialization of first of four patented technologies Company’s increasing revenues and continued...
May 11, 2016

OncBioMune Provides Update on Phase 2 Clinical Trials of ProscaVax for Prostate Cancer

OncBioMune Pharmaceuticals (OTCMKTS:OBMP) announced an update on the clinical advancement of ProscaVax, the Company’s novel cancer vaccine in development for...
May 4, 2016

Scripps Research Institute Spin-off iGenomX Launches with Transformational New Library Construction Technology for DNA Sequencing

SAN DIEGO–(BUSINESS WIRE)–Veteran academic and industry genome experts have joined together to launch iGenomX, a precision library construction company for...